Applied Therapeutics Announces Board Changes and Officer Compensation
| Field | Detail |
|---|---|
| Company | Applied Therapeutics, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
TL;DR
Applied Therapeutics swapped a director, elected a new one, and updated exec pay. Board changes are in.
AI Summary
Applied Therapeutics, Inc. announced on June 15, 2025, the departure of Director Dr. Shailesh V. Ganu and the election of Dr. David M. Roth to the Board of Directors. The company also disclosed compensatory arrangements for certain officers and provided a Regulation FD disclosure.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Board changes and executive compensation disclosures can sometimes precede or accompany significant strategic shifts or financial events, warranting closer investor scrutiny.
Key Players & Entities
- Applied Therapeutics, Inc. (company) — Registrant
- Dr. Shailesh V. Ganu (person) — Departing Director
- Dr. David M. Roth (person) — Elected Director
- June 15, 2025 (date) — Date of earliest event reported
FAQ
Who has departed from the Board of Directors?
Dr. Shailesh V. Ganu has departed from the Board of Directors.
Who has been elected to the Board of Directors?
Dr. David M. Roth has been elected to the Board of Directors.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is June 15, 2025.
What other items are disclosed in this 8-K filing besides director changes?
The filing also includes information on compensatory arrangements of certain officers, Regulation FD disclosure, and other events.
What is the state of incorporation for Applied Therapeutics, Inc.?
Applied Therapeutics, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 17, 2025 by Dr. Shailesh V. Ganu regarding Applied Therapeutics, Inc..